Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications.
Saeki Y, Mima T, Ishii T, Ogata A, Kobayashi H, Ohshima S, Ishida T, Tabunoki Y, Kitayama H, Mizuki M, Katada Y, Asaoku H, Kitano M, Nishimoto N, Yoshizaki K, Maeda M, Kon S, Kinoshita N, Uede T, Kawase I.
Saeki Y, et al.
Br J Haematol. 2003 Oct;123(2):263-70. doi: 10.1046/j.1365-2141.2003.04589.x.
Br J Haematol. 2003.
PMID: 14531907
Free article.